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SYNOPSIS 43
Background 44 mcr-1-mediated transmissible colistin resistance in Enterobacteriaceae is concerning, 45
given colistin is frequently used as a treatment of last resort in multidrug-resistant 46
Enterobacteriaceae infections. Reported rates of human mcr-1 gastrointestinal carriage 47 have historically been low. 48
Objectives 49
To identify trends in human gastrointestinal carriage of mcr-1 positive and mcr-1-50 positive/cefotaxime-resistant Enterobacteriaceae in Guangzhou, China, 2011-2016, and 51 investigate the genetic contexts of mcr-1 in a subset of mcr-1-positive/cefotaxime-52 resistant strains using whole genome sequencing (WGS). 53
Methods 54
Of 8,022 faecal samples collected, 497 (6.2%) were mcr-1-positive, and 182 (2.3%) mcr-55 1-positive/cefotaxime-resistant. Trends in carriage were assessed using iterative 56 sequential regression. A subset of mcr-1-positive isolates was sequenced (Illumina), and 57 genetic contexts of mcr-1 were characterised. 58
INTRODUCTION 78
The polymyxins, including colistin, are antibiotics of last resort for managing multidrug-79 resistant Gram-negative infections, including Pseudomonas aeruginosa, Acinetobacter 80 spp. and Enterobacteriaceae. Acquired resistance in these organisms has historically 81 largely been due to: mutation-based modifications to cell wall lipopolysaccharides; 82 utilization of efflux pumps; and capsule formation [1] . Transmissible colistin resistance, 83 encoded by mcr-1, was recently identified in Escherichia coli and Klebsiella pneumoniae 84 8 using the cetyl-trimethyl-ammonium bromide (CTAB)/chloroform method 146 (Supplementary material). Multi-locus sequence type was available for a subset (25/187) 147 using a standard approach (protocols at http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). 148 149 DNA extracts were sequenced on the Illumina HiSeq 4000 platform, using both paired-150 end (150bp reads, ~350bp insert) and mate-pair (50bp reads, ~6kb insert) approaches 151 (n=69 isolates) or paired-end reads only (n=20 isolates; Table S1 ). Libraries were 152 prepared using standardized protocols incorporating fragmentation by ultra-sonication, 153 end repair, adaptor ligation, and PCR amplification (Supplementary material) . 154
155
Preliminary species identification for isolates was derived from WGS using Kraken[25] ; 156 read-data were then mapped to a species-specific reference [26] . Hybrid de novo 157 assemblies of paired-end and mate-pair data, or paired-end data alone, were generated 158 using SPAdes[27] version 3.6 with the "--careful" option, a set of automatically 159 determined k-mer values (21, 33, 55, 77) , and by removing contigs <500bp or with k-mer 160 coverage <1. In silico MLST was determined using BLASTn and publicly available 161 databases for relevant species (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli, 162 http://bigsdb.web.pasteur.fr/klebsiella/klebsiella.html). Resistance genes were identified 163 from de novo assemblies using an in-house, curated database of resistance genes [28] and 164 BLASTn/mapping-based identification (scripts available at: 165 https://github.com/hangphan/resisType). Contigs were annotated using PROKKA [29] . 166
Contigs containing mcr-1 were defined as "plasmid" if they contained annotations 167 consistent with plasmid-associated loci and no obvious chromosomal loci, or 168 "chromosomal" if >75% of annotations (excluding hypothetical proteins) were consistent 169 with a chromosomal location. 170
171
The integrity of assemblies containing mcr-1 in chromosomal locations was assessed 172 using the REAPR tool [30] . We excluded any sequences with assembly sizes ≥6.5Mb; 173 mixed calls from in silico MLST or species identification; and mismatches between 174 available laboratory-based and WGS in silico MLST. 175
176
Phylogenies were reconstructed using IQtree[31] with a generalized time reversible 177 nucleotide substitution model and a gamma distribution allowing for substitution rate 178 variation among sites (GTR+G setting), using a starting tree inferred by maximum 179 parsimony. Branch lengths were corrected for recombination using ClonalFrameML 180 (default settings, kappa estimated from IQtree=2.75543) [32] . Insertion sequences (IS) 181 were downloaded from ISFinder (https://www-is.biotoul.fr); sequence assemblies were 182 queried with BLASTn (presence requiring >95% sequence identity over >90% of the 183 reference sequence length) against this database. 184
185
Circularization of mcr-1-harboring plasmid contigs was confirmed using Bandage [33] . 186
For single mcr-1-harboring plasmid contigs which could not be fully circularized, we also 187 used Bandage to visualize the sequencing assembly graph generated by SPAdes and 188 manually resolved the most likely mcr-1 plasmid structures based on node (contig) 189 (Table S1) . 197
198

RESULTS
199
Of 8,022 samples collected during the 5-year study, 497 (6.2%) were mcr-1-positive, and 200 182 (2.3%) mcr-1-positive and cefotaxime-resistant (Fig.S1 ). The proportion of both 201 mcr-1-positive and mcr-1-positive/cefotaxime-resistant faecal samples increased 202 significantly during the study (p<0.001). For mcr-1-positive/cefotaxime-resistant 203 samples, this was driven by a specific increase after January 2014 (p<0.001, Fig.1 resistance mechanism could be identified (Table S1 ). Multiple other resistance genes 244 identified included: (i) bla TEM-1 (n=37), bla (2), bla (1), bla (1), bla TEM- Table S1) . 248
249
The genetic context of mcr-1 was similarly diverse, supporting the potential for mcr-1 to 250 have spread widely, and in combination with other resistance genes. In 41/50 (82%) 251 isolates mcr-1 was located on plasmid-associated contigs, in 4 (8%) on chromosomal 252 contigs, in 2 (4%) likely on chromosomal contigs, and in 3 (6%) the location was unclear 253 due to assembly/annotation limitations. mcr-1 copy number was estimated at up to 3.54 254 (median 0.97, inter-quartile range: 0.79-1.39); likely due to its presence either on multi-255 copy plasmids; as multiple copies within the same plasmid structure ( In 14 (34%) isolates mcr-1 co-localized to a contig with either IncHI2A or IncHI2+HI2A 299 (n=8), or was plausibly associated with an IncHI2 plasmid based on assembly 300 visualization. These plasmids are typically large, and we were unable to reconstruct any 301 complete IncHI2A plasmids from the sequencing data. Four contigs were short 302 (<3,000bp); the rest are represented in Fig.4 , alongside two closed reference mcr-1 303 IncHI2 plasmids, pSA26 (Accession number: KU743384, bacteraemia, Saudi Arabia), 304 and pHNSHP45-2 (Accession number: KU341381, pig faeces isolate, Shanghai, China). 305
This alignment demonstrates a relatively homogenous plasmid backbone circulating 306 within the study population between 2014-early 2016, likely derived from an ancestral 307 plasmid structure similar to the reference plasmids, with some rearrangement/inversion 308 events, particularly around a region enriched for resistance genes and transposable 309 elements (Fig.4) . Within the study isolates, sampled over 3.5 years, we observed 310 apparently frequent IS/transposon-associated indel events, including of ISApl1, which 311 was either at the 5' end of mcr-1 (e.g. SYSU0003), flanking it on both sides (e.g. 312 SYSU0014), or absent (e.g. SYSU0026). As mcr-1 was located in the same wider genetic 313 context in 9/10 study plasmid contigs, this likely represents a single ISApl1-mcr-1-ISApl1 314 acquisition and subsequent loss of ISApl1 elements [35] . Alternatively it could represent a 315 "hotspot" for multiple insertion events of this complex. We also observed a mcr-1 316 duplication event within an otherwise identical contiguous plasmid sequence in two 317 isolates taken 7 days apart from different patients (both E. coli ST1684; SYSU0077, 318 SYSU0s078); and an inversion of ISApl1-mcr-1 within the plasmid backbone 319 (SYSU0002), all consistent with high rates of plasticity involving the ISApl1-mcr-1 and 320
IncHI2/HI2A structures. Other variation in the IncHI2+HI2A backbone in study isolates 321 included: (i) single nucleotide variants (SNVs), (ii) small indels (<20bp), (iii) clustered 322 SNVs suggestive of local recombination events, and (iv) gain and loss of several insertion 323
sequences. 324 325
In seven (15%) isolates mcr-1 co-localized to (n=6) or was plausibly associated with 326 (n=1) an X4-harboring contig; in four the contigs could be fully circularized, likely 327 representing complete plasmid structures (Fig.5) . These sequences had a highly 328 conserved, syntenic plasmid backbone, with limited nucleotide and indel variation, 329 including to two reference IncX4-mcr-1 plasmids, SZ04 (inpatient peritoneal fluid, 330
Suzhou, China) and pAF48 (urine, Johannesburg, South Africa). ISApl1 was absent in all 331 of these plasmids; the only consistently associated IS was an IS26 or highly similar 332 IS15DIV element 4.7kb upstream of mcr-1. 333
334
In 11 (27%) isolates no co-located or plausibly associated plasmid replicon could be 335 identified, and in one isolate (16EY645) we identified a new mcr-1 harbouring plasmid 336 structure, p16EY645_1, of 48,944bp (Fig.S2) . 94% of p16EY645_1 shared 99% 337 sequence identity with a larger IncP plasmid pHNFP671 (82,807bp, accession number: 338 KP324830.1), isolated from pig faeces obtained prior to 2014 in Guangzhou, China (the 339 study region); but p16EY645_1 itself has no typeable replicon. 340
341
Chromosomal mcr-1 integration was confirmed in four E. coli STs (457, 1114 STs (457, , 1684 2936), and plausibly occurred in two others (101, 2705) , consistent with at least four-six 343 independent chromosomal integration events in diverse E. coli strains (12% sequenced E. 344 coli isolates), providing capacity for widespread dissemination at the organism level. In 345 three of these isolates (SYSU0021, SYSU0219, SYSU0112), ISApl1 flanked mcr-1 on 346 both sides (with AT-AT, AC-CC as the composite transposon target site sequences 347
[TSS], or indeterminate TSS due to contig breaks). In one isolate mcr-1 was downstream 348 of a single ISApl1 unit (SYSU0225); in one flanked by a previously un-described 349 Widespread transmissible colistin resistance is of major concern in the current era of 356 multidrug-resistant Gram-negative infections, as colistin is commonly used to treat 357 infections caused by these organisms, despite its nephrotoxicity, and issues with 358 determining susceptibility and appropriate dosing regimens [37, 38] . In this, the largest 359 study of faecal carriage and WGS of mcr-1 isolates to date, we observed alarming 360 sequential increases in human faecal carriage of mcr-1-positive and cefotaxime-resistant, 361 third-generation cephalosporin-resistant E. coli over 5 years. We also found high genetic 362 plasticity and multidrug resistance of MGEs harbouring mcr-1 in these regional data from 363
Guangzhou, China, that may explain some of the dramatic recent increases in human 364 faecal carriage over the last two years. 
IS15DIV). 414 415
This study has several limitations. Firstly, although we observed significant increases in 416 faecal carriage of mcr-1-harboring isolates, we were unable to assess the possible risk 417 factors associated with increasing incidence. Secondly, our sampling strategy targeted 418 limited numbers of colistin-resistant isolates within faecal samples, and the diversity of E. 419 coli and likely other Enterobacteriaceae strains in the gastrointestinal tract is 420 substantial [50] . Our results could therefore underestimate the genetic diversity of strains 421
and MGEs harbouring mcr-1, particularly within individual hosts. Finally, due to 422 resource limitations we were unable to sequence all mcr-1-positive isolates, or to re-423 sequence those representing mixtures on sequencing. We were also unable to undertake 424 any long-read sequencing, increasingly the method of choice in assembling plasmids. 
